Explore All Access
Check if your research matches the topics covered in PharmacoEconomics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
PharmacoEconomics : Impact Factor & More
eISSN: 1179-2027pISSN: 1170-7690
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
PharmacoEconomics is a peer-reviewed medical journal published by Adis International (Springer Nature) that covers the fields of health economics, pharmacoeconomics, and quality-of-life assessment.
PharmacoEconomics Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
H-Index
112
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.85
Topics Covered on PharmacoEconomics
Migraine
Personalized medicine
Economic evaluation
Breast cancer
Multiple sclerosis
Systematic review
Dexamethasone
Initial treatment
Quality of life
Lung cancer
Extrapolation
Economic model
Anaplastic lymphoma kinase
Rare disease
Major depressive disorder
Decision model
Budget impact
Everolimus
Indirect costs
Circulating tumor DNA
PharmacoEconomics Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in PharmacoEconomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in PharmacoEconomics
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment.
- 6 Dec 2024
- PharmacoEconomics
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Difference Analyses Using the UK Household Longitudinal Survey.
- 5 Dec 2024
- PharmacoEconomics
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.
- 4 Dec 2024
- PharmacoEconomics
Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective.
- 3 Dec 2024
- PharmacoEconomics
Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis.
- 2 Dec 2024
- PharmacoEconomics
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?
- 1 Dec 2024
- PharmacoEconomics
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment.
- 6 Dec 2024
- PharmacoEconomics
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Difference Analyses Using the UK Household Longitudinal Survey.
- 5 Dec 2024
- PharmacoEconomics
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer.
- 4 Dec 2024
- PharmacoEconomics
Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective.
- 3 Dec 2024
- PharmacoEconomics
Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis.
- 2 Dec 2024
- PharmacoEconomics
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?
- 1 Dec 2024
- PharmacoEconomics
Compare Similar Journals with PharmacoEconomics
Select Journals to Compare with PharmacoEconomics
Total journals - 9
You can select up to 3 Journals at a time
Value in Health
Publisher: ELSEVIER SCIENCE INC
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Journal of Medical Economics
Publisher: TAYLOR & FRANCIS LTD
Expert Review of Pharmacoeconomics and Outcomes Research
Publisher: TAYLOR & FRANCIS LTD
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
PharmacoEconomics - Open
Publisher: SPRINGER INT PUBL AG
Applied Health Economics and Health Policy
Publisher: SPRINGER INT PUBL AG
International Journal of Technology Assessment in Health Care
Publisher: CAMBRIDGE UNIV PRESS
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
0 Journals Selected to compare with
PharmacoEconomics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on PharmacoEconomics
How long has PharmacoEconomics been actively publishing? 
PharmacoEconomics has been in operation since 1992 till date.
What is the publishing frequency of PharmacoEconomics?
PharmacoEconomics published with a Monthly frequency.
How many articles did PharmacoEconomics publish last year?
In 2023, PharmacoEconomics publsihed 111 articles.
What is the eISSN & pISSN for PharmacoEconomics?
For PharmacoEconomics, eISSN is 1179-2027 and pISSN is 1170-7690.
What is Citescore for PharmacoEconomics?
Citescore for PharmacoEconomics is 7.5.
What is the H Index for PharmacoEconomics ?
H Index for PharmacoEconomics is 112.
What is SNIP score for PharmacoEconomics?
SNIP score for PharmacoEconomics is 1.85.
What is the SJR for PharmacoEconomics?
SJR for PharmacoEconomics is Q1.
Who is the publisher of PharmacoEconomics?
ADIS INT LTD is the publisher of PharmacoEconomics.
